These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 22262194)
1. Serum levels of matrix metalloproteinases: implications in clinical neurology. Romi F; Helgeland G; Gilhus NE Eur Neurol; 2012; 67(2):121-8. PubMed ID: 22262194 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods. Sokolowska B; Jozwik A; Niebroj-Dobosz I; Janik P; Kwiecinski H J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():117-20. PubMed ID: 20134051 [TBL] [Abstract][Full Text] [Related]
3. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura. Mannello F Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213 [TBL] [Abstract][Full Text] [Related]
4. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. Roderfeld M; Rath T; Schulz R; Seeger W; Tschuschner A; Graf J; Roeb E J Cyst Fibros; 2009 Sep; 8(5):338-47. PubMed ID: 19604728 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. Dietmann A; Helbok R; Lackner P; Issifou S; Lell B; Matsiegui PB; Reindl M; Schmutzhard E; Kremsner PG J Infect Dis; 2008 Jun; 197(11):1614-20. PubMed ID: 18700258 [TBL] [Abstract][Full Text] [Related]
6. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy. Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463 [TBL] [Abstract][Full Text] [Related]
7. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients. Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088 [TBL] [Abstract][Full Text] [Related]
8. High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: a preliminary report. Melo GD; Marangoni NR; Marcondes M; Lima VM; Machado GF Vet J; 2011 May; 188(2):243-5. PubMed ID: 20418130 [TBL] [Abstract][Full Text] [Related]
9. Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target. Fontana V; Silva PS; Belo VA; Antonio RC; Ceron CS; Biagi C; Gerlach RF; Tanus-Santos JE Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):130-7. PubMed ID: 21401887 [TBL] [Abstract][Full Text] [Related]
10. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis. Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092 [TBL] [Abstract][Full Text] [Related]
13. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS). Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650 [TBL] [Abstract][Full Text] [Related]
14. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis]. Klimiuk PA; Sierakowski S; Chwiećko J Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814 [TBL] [Abstract][Full Text] [Related]
15. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Bar-Or A; Nuttall RK; Duddy M; Alter A; Kim HJ; Ifergan I; Pennington CJ; Bourgoin P; Edwards DR; Yong VW Brain; 2003 Dec; 126(Pt 12):2738-49. PubMed ID: 14506071 [TBL] [Abstract][Full Text] [Related]
16. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. Yushchenko M; Mäder M; Elitok E; Bitsch A; Dressel A; Tumani H; Bogumil T; Kitze B; Poser S; Weber F J Neurol; 2003 Oct; 250(10):1224-8. PubMed ID: 14586607 [TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495 [TBL] [Abstract][Full Text] [Related]